|
|||||
|
|
Pressure to respond: Hypertension predicts clinical benefit from bevacizumab in recurrent ovarian cancer |
|
| Authors: | A. Nick R. Stone P. Soliman A. Sood D. Gershenson R. Coleman P. Ramirez |
| Affiliation: | University of Texas M.D. Anderson Cancer Center, Houston, TX |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |